Financials Bioteque Corporation

Equities

4107

TW0004107008

Medical Equipment, Supplies & Distribution

End-of-day quote Taipei Exchange 06:00:00 2024-05-06 pm EDT 5-day change 1st Jan Change
123 TWD 0.00% Intraday chart for Bioteque Corporation +1.23% +11.82%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024
Capitalization 1 9,043 9,217 7,935 7,727 7,623 8,524
Enterprise Value (EV) 1 9,043 9,217 7,935 7,727 7,623 8,524
P/E ratio - - - - - -
Yield 3.07% 3.01% - 4.04% - -
Capitalization / Revenue 4,864,938 x 4,732,178 x 4,346,589 x - - -
EV / Revenue 4,864,938 x 4,732,178 x 4,346,589 x - - -
EV / EBITDA - - - - - -
EV / FCF 18,684,161 x 19,918,350 x -97,208,692 x - - -
FCF Yield 0% 0% -0% - - -
Price to Book 3.64 x 3.46 x 2.83 x 2.55 x 2.39 x -
Nbr of stocks (in thousands) 69,298 69,298 69,298 69,298 69,298 69,298
Reference price 2 130.5 133.0 114.5 111.5 110.0 123.0
Announcement Date 3/18/20 3/17/21 3/15/22 3/16/23 3/12/24 -
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 1,613 1,859 1,948 1,825 2,010 1,945
EBITDA 1 575.1 670.9 711 662.6 698.9 721.3
EBIT 1 489.2 580.5 606.7 547.9 578.4 580.2
Operating Margin 30.33% 31.23% 31.15% 30.02% 28.77% 29.83%
Earnings before Tax (EBT) 1 515.3 592.6 601.8 538.2 623.2 569.5
Net income 1 405 464.2 488.7 431.3 493.5 452.6
Net margin 25.11% 24.97% 25.09% 23.62% 24.55% 23.27%
EPS 2 5.810 6.670 7.020 6.200 7.090 6.500
Free Cash Flow 1 230 347.5 378 -8.474 -237.5 459.5
FCF margin 14.26% 18.69% 19.41% -0.46% -11.81% 23.63%
FCF Conversion (EBITDA) 39.98% 51.79% 53.16% - - 63.7%
FCF Conversion (Net income) 56.78% 74.86% 77.35% - - 101.53%
Dividend per Share 2 4.000 4.000 4.000 4.500 4.500 4.500
Announcement Date 4/1/19 3/18/20 3/17/21 3/25/22 3/16/23 3/12/24
1TWD in Million2TWD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2022 Q1 2022 Q2 2022 Q3 2023 Q1 2023 Q2
Net sales 1 443.4 - 486.5 523.7 455.9 472.3
EBITDA - - - - - -
EBIT 1 121.5 - 150.8 148 123.7 127.6
Operating Margin 27.41% - 31.01% 28.26% 27.13% 27.01%
Earnings before Tax (EBT) - - 161.1 169.3 124.2 -
Net income - 122.1 124.1 133.9 98.7 -
Net margin - - 25.51% 25.56% 21.65% -
EPS - 1.750 1.790 1.930 1.420 -
Dividend per Share - - - - - -
Announcement Date 11/11/21 5/16/22 8/12/22 11/11/22 5/12/23 8/11/23
1TWD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net Debt - - - - - -
Net Cash position - - - - - -
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 484 463 -81.6 - - -
ROE (net income / shareholders' equity) 19.3% - - - - -
ROA (Net income/ Total Assets) 16.3% - - - - -
Assets - - - - - -
Book Value Per Share 1 35.90 38.40 40.50 43.80 46.00 -
Cash Flow per Share - - - - - -
Capex 139 172 551 - - -
Capex / Sales 7.5% 8.82% 30.18% - - -
Announcement Date 3/18/20 3/17/21 3/15/22 3/16/23 3/12/24 -
1TWD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
123
Average target price
-
Consensus
  1. Stock Market
  2. Equities
  3. 4107 Stock
  4. Financials Bioteque Corporation
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW